Bai Z et al (2020) Protective effects of autophagy and NFE2L2 on reactive oxygen species-induced pyroptosis of human nucleus pulposus cells. Aging 12:7534–7548

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bermudez-Lekerika P et al (2022) Immuno-modulatory effects of intervertebral disc cells. Front Cell Dev Biol 10:924692

Article  PubMed  PubMed Central  Google Scholar 

Clouet J et al (2009) The intervertebral disc: from pathophysiology to tissue engineering. Joint Bone Spine 76:614–618

Article  PubMed  Google Scholar 

Dimozi A et al (2015) Oxidative stress inhibits the proliferation, induces premature senescence and promotes a catabolic phenotype in human nucleus pulposus intervertebral disc cells. Eur Cell Mater 30:89–102

Article  CAS  PubMed  Google Scholar 

Dydyk AM, Ngnitewe Massa R, Mesfin FB (2023) Disc herniation. In: StatPearls. 2023, StatPearls Publishing LLC, Treasure Island

Eraslan E et al (2019) Evodiamine alleviates kidney ischemia reperfusion injury in rats: a biochemical and histopathological study. J Cell Biochem 120:17159–17166

Article  CAS  PubMed  Google Scholar 

Fan X et al (2017) Evodiamine inhibits zymosan-induced inflammation in vitro and in vivo: inactivation of NF-κB by inhibiting IκBα phosphorylation. Inflammation 40:1012–1027

Article  CAS  PubMed  Google Scholar 

Ge J et al (2020) The protein tyrosine kinase inhibitor, genistein, delays intervertebral disc degeneration in rats by inhibiting the p38 pathway-mediated inflammatory response. Aging 12:2246–2260

Article  CAS  PubMed  PubMed Central  Google Scholar 

Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet, 2016. 388:1545–1602

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 Lancet, 390:1211–1259 (2017)

Gruber HE et al (2013) Mitochondrial bioenergetics, mass, and morphology are altered in cells of the degenerating human annulus. J Orthop Res 31:1270–1275

Article  ADS  PubMed  Google Scholar 

Guo XX et al (2018) Evodiamine induces apoptosis in SMMC-7721 and HepG2 cells by suppressing NOD1 signal pathway. Int J Mol Sci. https://doi.org/10.3390/ijms19113419

Article  PubMed  PubMed Central  Google Scholar 

Guo Q et al (2021) Targeting STING attenuates ROS induced intervertebral disc degeneration. Osteoarthritis Cartilage 29:1213–1224

Article  CAS  PubMed  Google Scholar 

Hayes AJ, Benjamin M, Ralphs JR (2001) Extracellular matrix in development of the intervertebral disc. Matrix Biol 20:107–121

Article  CAS  PubMed  Google Scholar 

Jin H et al (2019) Evodiamine inhibits RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss in mice. J Cell Mol Med 23:522–534

Article  CAS  PubMed  Google Scholar 

Johnson GL, Lapadat R (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298:1911–1912

Article  ADS  CAS  PubMed  Google Scholar 

Jordan J, Konstantinou K, O’Dowd J (2011) Herniated lumbar disc. BMJ Clin Evid 2011:1118

PubMed  PubMed Central  Google Scholar 

Kepler CK et al (2013) Expression and relationship of proinflammatory chemokine RANTES/CCL5 and cytokine IL-1β in painful human intervertebral discs. Spine (Phila Pa 1976) 38:873–880

Article  PubMed  Google Scholar 

Kong M et al (2021) Myocardin–related transcription factor a nuclear translocation contributes to mechanical overload–induced nucleus pulposus fibrosis in rats with intervertebral disc degeneration. Int J Mol Med 48:1–13

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kuai J, Zhang N (2022) Upregulation of SIRT1 by evodiamine activates PI3K/AKT pathway and blocks intervertebral disc degeneration. Mol Med Rep 26:1–8

Article  PubMed  PubMed Central  Google Scholar 

Le Maitre CL, Freemont AJ, Hoyland JA (2005) The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther 7:R732–R745

Article  PubMed  PubMed Central  Google Scholar 

Lee C (2018) Therapeutic modulation of virus-induced oxidative stress via the Nrf2-dependent antioxidative pathway. Oxid Med Cell Longev. https://doi.org/10.1155/2018/6208067

Article  PubMed  PubMed Central  Google Scholar 

Li Y et al (2022) Silencing ATF3 might delay TBHP-induced intervertebral disc degeneration by repressing NPC ferroptosis, apoptosis, and ECM degradation. Oxid Med Cell Longev 2022:4235126

PubMed  PubMed Central  Google Scholar 

Liu X et al (2020) Sodium butyrate protects against oxidative stress in human nucleus pulposus cells via elevating PPARγ-regulated klotho expression. Int Immunopharmacol 85:106657

Article  CAS  PubMed  Google Scholar 

Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402–408

Article  CAS  PubMed  Google Scholar 

Mao HJ et al (2011) The effect of injection volume on disc degeneration in a rat tail model. Spine (Phila Pa 1976) 36:E1062–E1069

Article  PubMed  Google Scholar 

Meng T et al (2021) Evodiamine inhibits lipopolysaccharide (LPS)-induced inflammation in BV-2 cells via regulating AKT/Nrf2-HO-1/NF-κB signaling axis. Cell Mol Neurobiol 41:115–127

Article  CAS  PubMed  Google Scholar 

Millward-Sadler SJ et al (2009) Regulation of catabolic gene expression in normal and degenerate human intervertebral disc cells: implications for the pathogenesis of intervertebral disc degeneration. Arthritis Res Ther 11:R65

Article  PubMed  PubMed Central  Google Scholar 

Raj PP (2008) Intervertebral disc: anatomy-physiology-pathophysiology-treatment. Pain Pract 8:18–44

Article  PubMed  Google Scholar 

Risbud MV, Shapiro IM (2014) Role of cytokines in intervertebral disc degeneration: pain and disc content. Nat Rev Rheumatol 10:44–56

Article  CAS  PubMed  Google Scholar 

Shi Y et al (2019) Protective effects of evodiamine against LPS-induced acute kidney injury through regulation of ROS-NF-κB-mediated inflammation. Evid Based Complement Alternat Med 2019:2190847

Article  PubMed  PubMed Central  Google Scholar 

Shin N et al (2020) p66shc siRNA-Encapsulated PLGA nanoparticles ameliorate neuropathic pain following spinal nerve ligation. Polymers (Basel). https://doi.org/10.3390/polym12051014

Article  PubMed  PubMed Central  Google Scholar 

Son JK, Chang HW, Jahng Y (2015) Progress in studies on rutaecarpine. II.—synthesis and structure-biological activity relationships. Molecules 20:10800–10821

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Q et al (2021) Evodiamine protects against airway remodelling and inflammation in asthmatic rats by modulating the HMGB1/NF-κB/TLR-4 signalling pathway. Pharm Biol 59:192–199

Article  CAS  PubMed  Google Scholar 

Wu P, Chen Y (2019) Evodiamine ameliorates paclitaxel-induced neuropathic pain by inhibiting inflammation and maintaining mitochondrial anti-oxidant functions. Hum Cell 32:251–259

Article  CAS  PubMed  Google Scholar 

Xian S et al (2022) The protective effect of evodiamine in osteoarthritis: an in vitro and in vivo study in mice model. Front Pharmacol 13:899108

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xin J et al (2022) Treatment of intervertebral disc degeneration. Orthop Surg 14:1271–1280

Article  PubMed  PubMed Central  Google Scholar 

Xue Y et al (2018) Evodiamine attenuates P2X(7)-mediated inflammatory injury of human umbilical vein endothelial cells exposed to high free fatty acids. Oxid Med Cell Longev 2018:5082817

Article  PubMed  PubMed Central  Google Scholar 

Yang JY et al (2021) Evodiamine inhibits Helicobacter pylori Growth and Helicobacter pylori-induced inflammation. Int J Mol Sci. https://doi.org/10.3390/ijms22073385

Article  PubMed  PubMed Central  Google Scholar 

Yang Y et al (2022) Evodiamine relieve LPS-induced mastitis by inhibiting AKT/NF-κB p65 and MAPK signaling pathways. Inflammation 45:129–142

Article  CAS  PubMed  Google Scholar 

Ye C et al (2021) Evodiamine alleviates lipopolysaccharide-induced pulmonary inflammation and fibrosis by activating apelin pathway. Phytother Res 35:3406–3417